Belite Bio, Inc
BLTE
$183.16
-$9.69-5.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.83M | 29.58M | 19.77M | 14.62M | 10.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.21M | 67.59M | 54.31M | 47.19M | 40.00M |
| Operating Income | -84.21M | -67.59M | -54.31M | -47.19M | -40.00M |
| Income Before Tax | -77.61M | -62.39M | -49.38M | -42.55M | -36.14M |
| Income Tax Expenses | -- | 0.00 | 0.00 | 0.00 | 6.00K |
| Earnings from Continuing Operations | -77.61 | -62.39 | -49.38 | -42.55 | -36.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.61M | -62.39M | -49.38M | -42.55M | -36.14M |
| EBIT | -84.21M | -67.59M | -54.31M | -47.19M | -40.00M |
| EBITDA | -84.03M | -67.41M | -54.14M | -47.02M | -39.84M |
| EPS Basic | -2.30 | -1.92 | -1.55 | -1.36 | -1.18 |
| Normalized Basic EPS | -0.85 | -0.61 | -0.38 | -0.38 | -0.38 |
| EPS Diluted | -2.30 | -1.92 | -1.55 | -1.36 | -1.18 |
| Normalized Diluted EPS | -0.85 | -0.61 | -0.38 | -0.38 | -0.38 |
| Average Basic Shares Outstanding | 134.11M | 129.35M | 126.82M | 124.56M | 122.15M |
| Average Diluted Shares Outstanding | 134.11M | 129.35M | 126.82M | 124.56M | 122.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |